Alterity Therapeutics ATHE
NASDAQ ATHE
$4.60 +0.15 (+3.37%)
As of: Aug 21, 2026 · 12:10 PM EDT

Alterity Therapeutics (ATHE) EPS (Diluted) (2009 - 2024)

Alterity Therapeutics (ATHE) EPS (Diluted) (2009 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 139.71 Bn 131.86 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 86.55 Bn 78.55 Bn 3.93 Bn 12.23
3 Argenx Se 65.26 Bn 60.07 Bn 1.37 Bn 7.33
4 Moderna 59.81 Bn 54.67 Bn 52.00 Mn -1.96
5 BeOne Medicines 42.16 Bn 37.06 Bn 1.53 Bn 2.05
6 Alnylam Pharmaceuticals 31.87 Bn 28.56 Bn 992.69 Mn 1.19
7 BioNTech SE 28.13 Bn 9.74 Bn 668.28 Mn -0.72
8 Insmed 27.53 Bn 26.37 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.31 Bn 26.47 Bn - 0.15
10 Alterity Therapeutics 49.04 Mn 16.74 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 0.00
Jun 30, 2023 0.00
Jun 30, 2022 -0.04
Dec 31, 2019 -1.42
Jun 30, 2019 -3.24
Dec 31, 2018 -1.41
Jun 30, 2018 -2.34
Dec 31, 2017 -1.02
Jun 30, 2017 -1.98
Dec 31, 2016 -1.01
Jun 30, 2010 -1.59
Jun 30, 2009 -2.10